Daily Cannabis News Brief for 9/15/2026

Below is The Marijuana Herald’s Daily Cannabis News Brief for September 15, 2026. The Marijuana Herald publishes a new edition every weekday at around 3 p.m. Pacific Time. Previous editions are available here.

Michigan has surpassed $17 billion in combined adult-use and medical marijuana sales since regulated sales began, according to a new state report. August generated approximately $259.09 million in sales, bringing cumulative adult-use sales above $15.41 billion and medical sales above $1.63 billion. The Marijuana Herald estimates those combined sales have generated roughly $2.66 billion in state taxes.

New marijuana regulations took effect in Maryland September 14, allowing sublingual THC pouches while eliminating the requirement that marijuana packaging be plain. Pouches may generally contain up to 10 milligrams of THC per serving and 100 milligrams per package. Packaging must remain opaque, while expanded restrictions prohibit elements designed to appeal to children.

A new Rasmussen Reports poll finds that 55% of American adults consider marijuana use not dangerous, compared with 37% who say it is dangerous. The share viewing marijuana as dangerous fell five percentage points from 2025, while those considering it not dangerous increased four points. The survey included 1,234 adults and has a ±3 percentage point margin of error.

A new study published in the Journal of Cannabis Research identified 294 registered cannabis social clubs in Chile, finding substantial growth over the past decade. Researchers recorded 71 new registrations in 2024, more than double the 29 recorded in 2023 and the highest annual total examined. About 67% of identified clubs were located in Chile’s Metropolitan Region.

Aurora Cannabis is pushing back against Curaleaf Holdings’ effort to halt its at-the-market stock program during Curaleaf’s hostile takeover bid. Aurora says the financing program predates the takeover offer and is intended to support growth opportunities. Aurora’s board continues to recommend shareholders reject Curaleaf’s offer, arguing it undervalues the company and its international medical marijuana operations.

Colorado will expand required safety testing for marijuana concentrates September 28, requiring laboratories to screen products for 17 additional residual solvents that can remain after manufacturing. The change will increase the state’s specifically listed solvent testing panel from 13 substances to 30. Testing for an additional solvent, triethylamine, will begin later once regulators start enforcing that requirement.

Alabama’s third medical marijuana dispensary opened September 14 in Athens, continuing the rollout of a program that began retail sales in June after years of delays. BamaBloom is operated by GP6 Wellness and joins two Callie’s Apothecary locations already operating in Montgomery and Talladega. Additional dispensaries are planned across several communities, including Birmingham, Bessemer and Etowah County.

High Tide reported record quarterly revenue of $198.8 million for the three months ending July 31, up 33% from a year earlier and marking its fifth consecutive record quarter. Net income reached $12.7 million, compared with $832,000 a year earlier. The company now operates 232 Canna Cabana locations in Canada while continuing to expand its German medical marijuana business.

U.S. Customs and Border Protection is seeking three portable cannabis analyzers capable of measuring 18 cannabinoids for field laboratories and mobile operations. The agency plans to purchase LightLab3 analyzers from Orange Photonics, saying the stand-alone devices can separate, identify and quantify numerous cannabinoids without requiring smartphone or computer connections that could create cybersecurity concerns.

Nebraska’s latest medical marijuana regulatory updates will not become final until 2027, delaying additional business licensing as the state continues implementing its voter-approved program. Ten product manufacturer applications were submitted before the September 14 deadline, while regulators have scheduled an October 15 public hearing on proposed rules covering fees, registration and renewal procedures.

A new preclinical study found that nanovesicles derived from Cannabis sativa roots suppressed tumor progression and restored key immune responses in mice. Researchers found the treatment promoted dendritic cell maturation, restored T-cell populations following induced immunosuppression and strengthened tumor-fighting immune activity. The researchers say the findings support further investigation into cannabis root-derived nanovesicles as a potential cancer immunotherapy platform.